Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
3.320
-0.200 (-5.68%)
At close: Jun 13, 2025, 4:00 PM
3.340
+0.020 (0.60%)
After-hours: Jun 13, 2025, 6:18 PM EDT
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $1.96 million as of June 13, 2025. Its market cap has decreased by -71.46% in one year.
Market Cap
1.96M
Enterprise Value
1.08M
1-Year Change
-71.46%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since February 16, 2016, Protagenic Therapeutics's market cap has increased from $399.62K to $1.96M, an increase of 389.31%. That is a compound annual growth rate of 18.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |